Literature DB >> 20425264

Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention.

Michael Clearfield1.   

Abstract

Entities:  

Year:  2010        PMID： 20425264     DOI： 10.1007/s11883-009-0083-x

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  10 in total

1.  Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.

Authors:  Giuseppe Patti; Massimo Chello; Vincenzo Pasceri; Diego Colonna; Annunziata Nusca; Marco Miglionico; Andrea D'Ambrosio; Elvio Covino; Germano Di Sciascio
Journal:  J Am Coll Cardiol       Date:  2006-09-26       Impact factor: 24.094

2.  Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.

Authors:  Carlo Briguori; Gabriella Visconti; Amelia Focaccio; Bruno Golia; Alaide Chieffo; Alfredo Castelli; Marco Mussardo; Matteo Montorfano; Bruno Ricciardelli; Antonio Colombo
Journal:  J Am Coll Cardiol       Date:  2009-08-06       Impact factor: 24.094

3.  Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.

Authors:  Valerio Sanguigni; Pasquale Pignatelli; Luisa Lenti; Domenico Ferro; Alfonso Bellia; Roberto Carnevale; Manfredi Tesauro; Roberto Sorge; Renato Lauro; Francesco Violi
Journal:  Circulation       Date:  2005-02-01       Impact factor: 29.690

4.  HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.

Authors:  S Dimmeler; A Aicher; M Vasa; C Mildner-Rihm; K Adler; M Tiemann; H Rütten; S Fichtlscherer; H Martin; A M Zeiher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

5.  Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.

Authors:  Ping-Yen Liu; Yen-Wen Liu; Li-Jen Lin; Jyh-Hong Chen; James K Liao
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

6.  Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

Authors:  Vincenzo Pasceri; Giuseppe Patti; Annunziata Nusca; Christian Pristipino; Giuseppe Richichi; Germano Di Sciascio
Journal:  Circulation       Date:  2004-07-26       Impact factor: 29.690

7.  Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.

Authors:  Josef Veselka; David Zemánek; Petr Hájek; Martin Malý; Radka Adlová; Lucie Martinkovicová; David Tesar
Journal:  Am J Cardiol       Date:  2009-06-24       Impact factor: 2.778

8.  Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.

Authors:  Giuseppe Patti; Vincenzo Pasceri; Giuseppe Colonna; Marco Miglionico; Dionigi Fischetti; Gennaro Sardella; Antonio Montinaro; Germano Di Sciascio
Journal:  J Am Coll Cardiol       Date:  2007-03-27       Impact factor: 24.094

9.  Fluvastatin and perioperative events in patients undergoing vascular surgery.

Authors:  Olaf Schouten; Eric Boersma; Sanne E Hoeks; Robbert Benner; Hero van Urk; Marc R H M van Sambeek; Hence J M Verhagen; Nisar A Khan; Martin Dunkelgrun; Jeroen J Bax; Don Poldermans
Journal:  N Engl J Med       Date:  2009-09-03       Impact factor: 91.245

Review 10.  Pleiotropic effects of statins--clinical evidence.

Authors:  Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116
  10 in total
  2 in total

1.  Clinical effect of preoperative high-dose atorvastatin against no-reflow after PCI.

Authors:  Wenbo Liu; Zhipeng Zou; Haipeng Jiang; Qiang Li; Fangming Guo; Zhen Wang; Hongguang Zhu
Journal:  Exp Ther Med       Date:  2016-11-18       Impact factor: 2.447

2.  Comparison of the Treatment Efficacy of Rosuvastatin versus Atorvastatin Loading Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.

Authors:  Esraa M Adel; Ahmed A Elberry; Ahmed Abdel Aziz; Ibrahim A Naguib; Badrah S Alghamdi; Raghda R S Hussein
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.